Clinical Trial

An Open-label Study of GC012F in Rheumatoid Arthritis.

Withdrawn Early Phase 1
View on ClinicalTrials.gov →
Why the trial stopped
Due to the sponsor's adjustment of the research and development strategy for this clinical trial, this study was prematurely terminated, and no subjects were recruited for this study
Summary
This is An Open-label Study to Evaluate the Safety and Efficacy of GC012F in Patients with Difficult-to-Treat (D2T) Rheumatoid Arthritis.
Protocol Amendment History 2 changes
critical Trial status changed: Not Yet Recruiting → Withdrawn 2026-06-11
notable Enrollment reduced: 9 -> 0 participants 2026-06-11
Trial Details
NCT Number NCT07315503
Lead Sponsor Institute of Hematology & Blood Diseases Hospital, China
Conditions Rheumatoid Arthritis
Start Date 2027-12
Primary Completion 2028-01-15 (estimated)
Study Completion 2041-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-10